This company is no longer active
Salud financiera de hoja de balance de Selectimmune Pharma
Salud financiera controles de criterios 3/6
Selectimmune Pharma has a total shareholder equity of SEK6.1M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK7.1M and SEK1.0M respectively.
Información clave
0%
Ratio deuda-patrimonio
kr0
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | kr5.84m |
| Patrimonio | kr6.10m |
| Total pasivo | kr1.03m |
| Activos totales | kr7.13m |
Actualizaciones recientes sobre salud financiera
Análisis de la situación financiera
Pasivos a corto plazo: SELECT B's short term assets (SEK6.3M) exceed its short term liabilities (SEK1.0M).
Pasivo a largo plazo: SELECT B's short term assets (SEK6.3M) do not cover its long term liabilities (SEK-1.0).
Historial y análisis de deuda-patrimonio
Nivel de deuda: SELECT B is debt free.
Reducción de la deuda: SELECT B has not had any debt for past 5 years.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: SELECT B has less than a year of cash runway based on its current free cash flow.
Pronóstico de cash runway: SELECT B has less than a year of cash runway if free cash flow continues to reduce at historical rates of 24.5% each year